You are here » Home » Companies » Company Overview » Bajaj Healthcare Ltd

Bajaj Healthcare Ltd.

BSE: 539872 Sector: Health care
NSE: N.A. ISIN Code: INE411U01019
BSE 14:28 | 23 Feb 378.75 8.75
(2.36%)
OPEN

378.75

HIGH

378.75

LOW

378.75

NSE 05:30 | 01 Jan Bajaj Healthcare Ltd
OPEN 378.75
PREVIOUS CLOSE 370.00
VOLUME 400
52-Week high 410.00
52-Week low 260.00
P/E 33.28
Mkt Cap.(Rs cr) 261
Buy Price 360.00
Buy Qty 400.00
Sell Price 432.20
Sell Qty 400.00
OPEN 378.75
CLOSE 370.00
VOLUME 400
52-Week high 410.00
52-Week low 260.00
P/E 33.28
Mkt Cap.(Rs cr) 261
Buy Price 360.00
Buy Qty 400.00
Sell Price 432.20
Sell Qty 400.00

Bajaj Healthcare Ltd. (BAJAJHEALTHCARE) - Chairman Speech

Company chairman speech

Mr. Sajankumar R. Bajaj

Chairman & Managing Director

Dear Shareholder's

I am delighted to welcome you all for Twenty Fourth Annual General Meeting. We mustrecord our sincere thanks and appreciation to all those who have stood by us with theirinvestments. Your continued trust encouragement support and fair criticism based on dataand facts are what give us energy enthusiasm confidence and motivation to strive forbetterment!

Your Company believes in "Quality and Timely Delivery" and these have beenpillars of our Success in the National and International Markets. The combination ofoperational excellence and improved quality were the key drivers of our Company whichresulted in improved profitability.

Your Company Bajaj Healthcare Limited is a backward integrated pharmaceutical companywith manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs)Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins Amino AcidsAnti-Convulsants and Finished Dosage Forms (FDFs) catering to various therapeuticsegments.

Your Company has State – of – the – Art manufacturing and R&Dfacilities which will help us to make further inroads in highly regulated and challengingmarkets.

Your Company began its operations in the year 1993 with an API manufacturing unit inTarapur near Mumbai. Over the years we have expanded our scale and scope of operationsand currently we have enlarged our wings up to five (5) manufacturing units formanufacture of APIs Intermediates and Formulations. As part of this expansion in theyear 2006 we acquired a 46000 sq. mtrs. plant in Savli Vadodara for setting up one ofour biggest API and Intermediate manufacturing units. In the year 2008 with a view toenter into manufacturing of FDFs we acquired a 3000 sq. mtrs. Formulations plant atManjusar Vadodara and we have converted it into a state-of-the-art WHO-GMP compliantfacility. Keeping in momentum of the expansion in the year 2013 we set-up yet anotherAPI and Intermediate manufacturing unit at Panoli Ankleshwar. In the last fiscal i.e. inF. Y. 14-15 with the growing demand for APIs we decided to have a separate unit forIntermediate products so that the Savli and Panoli Units could concentrate on manufactureof APIs. Accordingly in November 2014 we acquired and set-up an Intermediate Unit inTarapur MIDC near Mumbai.

Your Company's Sales/Income from operation (Gross) stood at Rs. 23304.58 Lakhs ascompared to Rs. 22321.81 lakhs in the Previous Year.

In conclusion I would like to thank all our Stakeholders and Boards members for theircontinued trust guidance and Support. I am also grateful to our Customers VendorsBankers and Other Business Associates who have reposed their faith in us. I would alsolike to extend my appreciation to our employees for their commitment and contribution inour Company.

We remain focus about our future with a well balanced strategy and determination tomake the most of the available opportunities thereby creating greater value for all ourStakeholders

Your Sincerely

Sd/-

Sajankumar Bajaj

Chairman & Managing Director